Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer
作者
David E. Gerber,Mark A. Socinski,Joel W. Neal,Heather A. Wakelee,Keisuke Shirai,Lecia Van Dam Sequist,Rachel Pam Greenerger Rosovsky,Rogério Lilenbaum,Bruno R. Bastos,Chao Hui Huang,Melissa Lynne Johnson,Paul Joseph Hesketh,Deepa Suresh Subramaniam,Martin Frederik Dietrich,Feng Chai,Yunxia Wang,Julia Kazakin,Brian E. Schwartz,Joan H. Schiller,Julie Renee Brahmer
出处
期刊:Lung Cancer [Elsevier BV] 日期:2018-02-03卷期号:117: 44-49被引量:16